These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21928354)

  • 1. The ABC of non-inferiority margin setting from indirect comparisons.
    Julious SA
    Pharm Stat; 2011; 10(5):448-53. PubMed ID: 21928354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing a non-inferiority study in kidney transplantation: a case study.
    Witte S; Schmidli H; O'Hagan A; Racine A
    Pharm Stat; 2011; 10(5):427-32. PubMed ID: 21928323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect comparisons in the comparative efficacy and non-inferiority settings.
    Snapinn S; Jiang Q
    Pharm Stat; 2011; 10(5):420-6. PubMed ID: 21956948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active controlled studies in antibiotic drug development.
    Dane A
    Pharm Stat; 2011; 10(5):454-60. PubMed ID: 21956949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The network meta-analytic-predictive approach to non-inferiority trials.
    Schmidli H; Wandel S; Neuenschwander B
    Stat Methods Med Res; 2013 Apr; 22(2):219-40. PubMed ID: 22218367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-inferiority study design: lessons to be learned from cardiovascular trials.
    Head SJ; Kaul S; Bogers AJ; Kappetein AP
    Eur Heart J; 2012 Jun; 33(11):1318-24. PubMed ID: 22564354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidential approach to non-inferiority clinical trials.
    Wang SJ; Blume JD
    Pharm Stat; 2011; 10(5):440-7. PubMed ID: 21928286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-creep in non-inferiority clinical trials.
    Everson-Stewart S; Emerson SS
    Stat Med; 2010 Nov; 29(27):2769-80. PubMed ID: 20809482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing methods for calculating confidence intervals for vaccine efficacy.
    Ewell M
    Stat Med; 1996 Nov 15-30; 15(21-22):2379-92. PubMed ID: 8931208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.
    Koopmeiners JS; Hobbs BP
    Stat Methods Med Res; 2018 May; 27(5):1547-1558. PubMed ID: 27587591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ; Hung HM
    Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
    Shao Y; Mukhi V; Goldberg JD
    Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.